Skip to content

Clinical trials

Phase 2 Autoimmune Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 2 Country / region: Australia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20192
20202
20212
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Beeline Medicines Corporation1
Imcyse SA1
ImmusanT, Inc.1
Institut de Recherches Internationales Servier1
Jade Biosciences, Inc.1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Victor Chang Cardiac Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases9
Immune System Diseases4
Sjogren's Syndrome3
Arthritis2
Connective Tissue Diseases2
Diabetes Mellitus, Type 12
Glomerulonephritis2
Glomerulonephritis, IGA2
Joint Diseases2
Kidney Diseases2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.